Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study
Objectives Pulmonary involvement is common in systemic lupus erythematosus (SLE), but the relative risk of pulmonary manifestations in SLE versus non-SLE subjects remains unclear. This study aimed to evaluate the risk of pulmonary manifestations in SLE subjects compared with matched controls.Methods...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-02-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/11/1/e005267.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850079676654944256 |
|---|---|
| author | Hyun Lee Bo-Guen Kim Yeonghee Eun Dong Won Park Sang-Heon Kim Jiyeong Kim |
| author_facet | Hyun Lee Bo-Guen Kim Yeonghee Eun Dong Won Park Sang-Heon Kim Jiyeong Kim |
| author_sort | Hyun Lee |
| collection | DOAJ |
| description | Objectives Pulmonary involvement is common in systemic lupus erythematosus (SLE), but the relative risk of pulmonary manifestations in SLE versus non-SLE subjects remains unclear. This study aimed to evaluate the risk of pulmonary manifestations in SLE subjects compared with matched controls.Methods Using data from the Korean National Health Insurance Service (2009–2017), we identified 6074 individuals aged ≥20 years with newly diagnosed SLE and 60 740 matched controls by age and sex (1:10 ratio) who did not have prior pulmonary manifestations.Results Over a mean follow-up of 9.3±2.7 years, the incidence of pulmonary manifestations was 15.2 per 1000 person-years in the SLE cohort and 4.5 per 1000 person-years in the matched cohort. The SLE cohort had a significantly higher risk of pulmonary manifestations (adjusted HR (aHR) 3.26; 95% CI 2.99 to 3.56). The highest risk was observed for pulmonary hypertension (aHR 14.66; 95% CI 9.43 to 22.80), followed by interstitial lung disease (aHR 9.58; 95% CI 7.99 to 11.49), pleural disorders (aHR 3.29; 95% CI 2.84 to 3.81), pulmonary embolism (aHR 2.66; 95% CI 2.06 to 3.43), tuberculosis (aHR 2.35; 95% CI 1.88 to 2.93), acute respiratory distress syndrome and haemorrhage (aHR 1.85; 95% CI 1.51 to 2.25) and lung cancer (aHR 1.41; 95% CI 1.02 to 1.95).Conclusions Subjects with SLE have an approximately 3.3-fold higher risk of pulmonary manifestations compared with matched controls. Notably, the risks of pulmonary hypertension and interstitial lung disease are particularly elevated. |
| format | Article |
| id | doaj-art-cee8164354524e8c80b5757f29d23842 |
| institution | DOAJ |
| issn | 2056-5933 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | RMD Open |
| spelling | doaj-art-cee8164354524e8c80b5757f29d238422025-08-20T02:45:09ZengBMJ Publishing GroupRMD Open2056-59332025-02-0111110.1136/rmdopen-2024-005267Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal studyHyun Lee0Bo-Guen Kim1Yeonghee Eun2Dong Won Park3Sang-Heon Kim4Jiyeong Kim5Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea (the Republic of)1College of Medicine, The Catholic University of Korea, Seoul, KoreaDivision of Rheumatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Seoul, Korea (the Republic of)Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea (the Republic of)2Hanyang University College of Medicine, Internal Medicine, Seoul, Korea, Rep. of (South Korea)Department of Pre-Medicine, Hanyang University, Seoul, Korea (the Republic of)Objectives Pulmonary involvement is common in systemic lupus erythematosus (SLE), but the relative risk of pulmonary manifestations in SLE versus non-SLE subjects remains unclear. This study aimed to evaluate the risk of pulmonary manifestations in SLE subjects compared with matched controls.Methods Using data from the Korean National Health Insurance Service (2009–2017), we identified 6074 individuals aged ≥20 years with newly diagnosed SLE and 60 740 matched controls by age and sex (1:10 ratio) who did not have prior pulmonary manifestations.Results Over a mean follow-up of 9.3±2.7 years, the incidence of pulmonary manifestations was 15.2 per 1000 person-years in the SLE cohort and 4.5 per 1000 person-years in the matched cohort. The SLE cohort had a significantly higher risk of pulmonary manifestations (adjusted HR (aHR) 3.26; 95% CI 2.99 to 3.56). The highest risk was observed for pulmonary hypertension (aHR 14.66; 95% CI 9.43 to 22.80), followed by interstitial lung disease (aHR 9.58; 95% CI 7.99 to 11.49), pleural disorders (aHR 3.29; 95% CI 2.84 to 3.81), pulmonary embolism (aHR 2.66; 95% CI 2.06 to 3.43), tuberculosis (aHR 2.35; 95% CI 1.88 to 2.93), acute respiratory distress syndrome and haemorrhage (aHR 1.85; 95% CI 1.51 to 2.25) and lung cancer (aHR 1.41; 95% CI 1.02 to 1.95).Conclusions Subjects with SLE have an approximately 3.3-fold higher risk of pulmonary manifestations compared with matched controls. Notably, the risks of pulmonary hypertension and interstitial lung disease are particularly elevated.https://rmdopen.bmj.com/content/11/1/e005267.full |
| spellingShingle | Hyun Lee Bo-Guen Kim Yeonghee Eun Dong Won Park Sang-Heon Kim Jiyeong Kim Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study RMD Open |
| title | Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study |
| title_full | Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study |
| title_fullStr | Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study |
| title_full_unstemmed | Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study |
| title_short | Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study |
| title_sort | comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus a large scale korean population based longitudinal study |
| url | https://rmdopen.bmj.com/content/11/1/e005267.full |
| work_keys_str_mv | AT hyunlee comprehensiveriskassessmentforpulmonarymanifestationsinsystemiclupuserythematosusalargescalekoreanpopulationbasedlongitudinalstudy AT boguenkim comprehensiveriskassessmentforpulmonarymanifestationsinsystemiclupuserythematosusalargescalekoreanpopulationbasedlongitudinalstudy AT yeongheeeun comprehensiveriskassessmentforpulmonarymanifestationsinsystemiclupuserythematosusalargescalekoreanpopulationbasedlongitudinalstudy AT dongwonpark comprehensiveriskassessmentforpulmonarymanifestationsinsystemiclupuserythematosusalargescalekoreanpopulationbasedlongitudinalstudy AT sangheonkim comprehensiveriskassessmentforpulmonarymanifestationsinsystemiclupuserythematosusalargescalekoreanpopulationbasedlongitudinalstudy AT jiyeongkim comprehensiveriskassessmentforpulmonarymanifestationsinsystemiclupuserythematosusalargescalekoreanpopulationbasedlongitudinalstudy |